GRK6 and Parkinson disease: For instance, studies have shown that both GRK6 and CK2 targets α-syn for S129 phosphorylation [21, 27–29] and large proportion of the α-syn in PD brain samples are found to be phosphorylated at S129 whereas in control, most α-syn is not phosphorylated [19, 30].